This Solicitation opportunity from Government of Canada was posted on January 27, 2023. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Ciprofloxacin tablets or capsules, 500 mg
Closed
W6369-23-A055CanadaSubmission Closed
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
General Info
Agency
Government of Canada → Department of National DefenceView Agency
NAICS
N/A
Place of Performance
*Ontario (except NCR), CANSet-Aside
NONE
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
PhaseClosed
Submission Closed
Organization & Contact Information
Show more
AgencyGovernment of Canada → Department of National Defence
Contacts1 person available
OfficeN/A
Office AddressN/A
Contacts
Full Description
Show more
The Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), Department of National Defence (DND), has a requirement for Ciprofloxacin tablets or capsules for the treatment of Canadian Armed Forces (CAF) members who may have been exposed to bacterial biological warfare agents.Estimated quantity of commodity: 1,728,000Duration of contract: The period of the Contract is from date of Contract to 31 March 2026 inclusive.Time frame of delivery: No later than 15 March 2023